Prescription Profile of Antibiotic Drugs Post Excision Biopsy of Oral Soft Tissue Disease in Palembang
DOI:
https://doi.org/10.32539/bsm.v5i3.215Keywords:
Amoxicillin, Antibiotics, Excisional Biopsy, Dentist, EpulisAbstract
Backgroud An excisional biopsy is one of the surgical treatments given to cases of
small benign tumors in the soft tissues of the oral cavity. Antibiotics are prescribed
by dentists as a follow-up therapy after excisional biopsy to prevent bacterial
infection. The purpose of this study was to determine the profile of antibiotic drug
prescription after excision biopsy of oral soft tissue disease by dentists in Palembang.
Methods This type of research is descriptive observational with a survey method.
The research was carried out by distributing questionnaires to 40 dentists and
dental specialists in Palembang who had performed excision biopsy treatment for
oral soft tissue disease. Result The results showed that the antibiotic prescription
of amoxicillin was 55%, the combination of amoxicillin and clavulanic acid was
17.5%, and clindamycin was 12.5%. The cases found in this study were epulis
57.5%, mucocele 30%, and traumatic fibroma 10%. Conclusion It can be concluded
that the antibiotic most often prescribed by dentists in Palembang after excision
biopsy treatment was amoxicillin and the most common case was epulis.
Authors
- Nadhila Apriadhanti 1
- Nita Parisa2*
- Siti Rusdiana Puspa Dewi 1
- 1Dentistry Program, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia
- 2Department of Pharmacology, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia
Corresponding author Nita Parisa — nitaparisa@unsri.ac.id
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
